Meeting
2015 ASCO Annual Meeting
Effect of mutant TP53 genotypes on the outcome of breast cancer (BC) patients in different clinical tumor subtypes.
Authors
George Fountzilas
Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece
George Fountzilas , Meletios A. Dimopoulos , George Kouvatseas , Eleni Timotheadou , George E. Pentheroudakis , Helen Gogas , Dimitrios G. Pectasides , Christos Christodoulou , Elpida Charalambous , Aggeliki Lyberopoulou , Helena Linardou , Christos Papandreou , Amanda Psyrri , Gerasimos Aravantinos , Christos Markopoulos , Vasileios Venizelos , Ioannis Efstratiou , Konstantine T. Kalogeras , Sotiris Lakis , Vassiliki Kotoula
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 33, 2015 (suppl; abstr 11041)
DOI
10.1200/jco.2015.33.15_suppl.11041
Abstract #
11041
Poster Bd #
254
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Genomic characterization of the GATA3 mutational landscape in breast cancer.
First Author: Jason A Mouabbi
Poster
2020 ASCO Virtual Scientific Program
Genomic profiling of breast cancer brain metastases reveals targetable alterations.
First Author: Sheheryar Kairas Kabraji
Poster
2018 ASCO Annual Meeting
Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process.
First Author: Begona Jimenez Rodriguez
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Evaluation of a real-world clinico-genomics database of patients with upper gastrointestinal (GI) malignancies in Japan.
First Author: Senaka A. Peter